$AZN
Market Cap:
$AZN SEC Filings
| Filing | Filed On |
|---|---|
| BOARD COMMITTEE CHANGES | 26 Jun 2018 |
| PUBLICATION OF A PROSPECTUS | 22 Jun 2018 |
| UPDATE: LANABECESTAT PHASE III ALZHEIMER'S TRIALS | 12 Jun 2018 |
| EU APPROVES TAGRISSO FOR 1ST-LINE NSCLC | 08 Jun 2018 |
| DIRECTOR DECLARATION | 08 Jun 2018 |
| BLOCK LISTING INTERIM REVIEW | 01 Jun 2018 |
| TOTAL VOTING RIGHTS | 01 Jun 2018 |
| DIRECTOR DECLARATION | 01 Jun 2018 |
| UPDATE ON TERRANOVA PIII TRIAL FOR FASENRA IN COPD | 30 May 2018 |
| AZS IMFINZI: SIGNIFICANT OS IN STAGE III NSCLC | 25 May 2018 |
| AZ REGULATORY SUBMISSION IN JAPAN FOR FORXIGA | 21 May 2018 |
| US FDA APPROVES LOKELMA FOR ADULT HYPERKALAEMIA | 21 May 2018 |
| RESULT OF AGM | 18 May 2018 |
| AZN: Q1 2018 RESULTS | 18 May 2018 |
| ASTRAZENECA UPDATE ON FASENRA PIII TRIAL IN COPD | 11 May 2018 |
| EMA APPROVES LYNPARZA: MAINTENANCE OVARIAN CANCER | 08 May 2018 |
| AZ AND LUYE PHARMA ENTER AGREEMENT FOR SEROQUEL | 07 May 2018 |
| DIRECTOR DECLARATION | 04 May 2018 |
| TOTAL VOTING RIGHTS | 01 May 2018 |
| AZ: POSITIVE CHMP FOR TAGRISSO FIRST-LINE NSCLC | 27 Apr 2018 |
